Key terms

About VBIV

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VBIV news

Apr 16 8:49am ET VBI Vaccines Soars with Hepatitis B Vaccine Success by TipRanks Apr 11 4:37pm ET VBI Vaccines Completes $2 Million Offering by TipRanks Apr 11 4:24pm ET VBI Vaccines Raises $1.7 Million in Direct Share Offering by TipRanks Apr 11 11:20am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 09 4:37pm ET VBI Vaccines Raises $2 Million in Direct Offering by TipRanks Apr 05 10:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 04 11:03am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 03 8:39am ET VBI Vaccines Inc Release: Content Unintelligible by TipRanks Apr 03 8:12am ET VBI Vaccines to Present Early Phase 2b Cancer Vaccine Results by TipRanks Apr 03 8:06am ET VBI Vaccines presents data from Phase 2b study of VBI-1901 by TipRanks Apr 02 8:39am ET VBI Vaccines Boosts Canadian Govt Partnership by TipRanks Apr 02 8:12am ET VBI Vaccines Bolsters Collaboration with Canadian Government by TipRanks Apr 02 8:07am ET VBI Vaccines broadens deal with Canada on mRNA-launched vaccines by TipRanks Feb 14 7:23am ET VBI Vaccines gets $2.5M upfront in deal with Brii Bio for assets and licensing by TipRanks Feb 07 4:46am ET VBI Vaccines Secures Forbearance Agreement Extensions by TipRanks

No recent press releases are available for VBIV

VBIV Financials

1-year income & revenue

Key terms

VBIV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VBIV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching